274 related articles for article (PubMed ID: 33117294)
41. Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.
Wachtel H; Kennedy EH; Zaheer S; Bartlett EK; Fishbein L; Roses RE; Fraker DL; Cohen DL
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S646-54. PubMed ID: 26374407
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic goals in patients with pheochromocytoma: a guide to perioperative management.
Azadeh N; Ramakrishna H; Bhatia NL; Charles JC; Mookadam F
Ir J Med Sci; 2016 Feb; 185(1):43-9. PubMed ID: 26650752
[TBL] [Abstract][Full Text] [Related]
43. Acute myocardial infarction attributable to adrenergic crises in a patient with pheochromocytoma and neurofibromatosis 1.
Boulkina LS; Newton CA; Drake AJ; Tanenberg RJ
Endocr Pract; 2007; 13(3):269-73. PubMed ID: 17599858
[TBL] [Abstract][Full Text] [Related]
44. Pheochromocytoma and acute myocardial infarction.
Nirgiotis JG; Andrassy RJ
South Med J; 1990 Dec; 83(12):1478-80. PubMed ID: 2251539
[TBL] [Abstract][Full Text] [Related]
45. The intraoperative medical management of childhood pheochromocytoma.
Ellis D; Gartner JC
J Pediatr Surg; 1980 Oct; 15(5):655-9. PubMed ID: 6108356
[TBL] [Abstract][Full Text] [Related]
46. Pheochromocytoma.
Van Way CW; Scott HW; Page DL; Rhamy RK
Curr Probl Surg; 1974 Jun; ():1-59. PubMed ID: 4151795
[No Abstract] [Full Text] [Related]
47. Hereditary paraganglioma presenting with atypical symptoms: Case report.
Eguchi S; Ono R; Sato T; Yada K; Umehara N; Narumi S; Ichihashi Y; Nozaki T; Kanomata N; Hasegawa T; Ozawa M; Hasegawa D
Medicine (Baltimore); 2021 Nov; 100(46):e27888. PubMed ID: 34797335
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E; Osinga TE; Timmers HJLM; Lenders JWM; Feelders RA; Eekhoff EMW; Haak HR; Corssmit EPM; Bisschop PHLT; Valk GD; Veldman RG; Dullaart RPF; Links TP; Voogd MF; Wietasch GJKG; Kerstens MN
J Clin Endocrinol Metab; 2020 Jul; 105(7):2381-91. PubMed ID: 31714582
[TBL] [Abstract][Full Text] [Related]
49. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Takekoshi K; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Asada S; Kawata N; Naruse M
Endocr J; 2019 Dec; 66(12):1063-1072. PubMed ID: 31511435
[TBL] [Abstract][Full Text] [Related]
50. [Preoperative and postoperative management of adrenal masses].
Paragliola RM; Ricciato MP; Gallo F; De Rosa A; Ianni F; Locantore P; Senes P; Pontecorvi A; Corsello SM
G Chir; 2010; 31(6-7):332-5. PubMed ID: 20646386
[TBL] [Abstract][Full Text] [Related]
51. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.
Yang Y; Zhang J; Fang L; Jia X; Zhang W
Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769
[TBL] [Abstract][Full Text] [Related]
52. Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.
Seamon ML; Yamaguchi I
Curr Hypertens Rep; 2021 May; 23(5):32. PubMed ID: 34041599
[TBL] [Abstract][Full Text] [Related]
53. [Premedication in pheochromocytoma].
Förster G; Schulz G; Kahaly G
Zentralbl Chir; 1997; 122(6):454-9. PubMed ID: 9334112
[TBL] [Abstract][Full Text] [Related]
54. [Pheochromocytoma. Preoperative preparation. Per- and postoperative complications].
Gilsanz FJ
Rev Esp Anestesiol Reanim; 1983; 30(1):30-6. PubMed ID: 6134307
[No Abstract] [Full Text] [Related]
55. Difficult-to-control hypertension.
Elmi F; Quintana B; Yousefi A
Mayo Clin Proc; 2000 Jun; 75(6):655-6. PubMed ID: 10852431
[No Abstract] [Full Text] [Related]
56. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.
Naruse M; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Harada T; Kawata N; Takekoshi K
Endocr J; 2018 Mar; 65(3):359-371. PubMed ID: 29353821
[TBL] [Abstract][Full Text] [Related]
57. Successful outcomes in pheochromocytoma surgery in the modern era.
Ulchaker JC; Goldfarb DA; Bravo EL; Novick AC
J Urol; 1999 Mar; 161(3):764-7. PubMed ID: 10022680
[TBL] [Abstract][Full Text] [Related]
58. Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report.
Thanapaalasingham K; Pollmann AS; Schelew B
Can J Anaesth; 2015 Dec; 62(12):1303-7. PubMed ID: 26362800
[TBL] [Abstract][Full Text] [Related]
59. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
Matsuura H; Koyama S; Tsuchioka Y; Yoshida M; Kurogane H
Horumon To Rinsho; 1982 Dec; 30(12):1439-46. PubMed ID: 6130862
[No Abstract] [Full Text] [Related]
60. Adrenergic myocarditis in pheochromocytoma.
Roghi A; Pedrotti P; Milazzo A; Bonacina E; Bucciarelli-Ducci C
J Cardiovasc Magn Reson; 2011 Jan; 13(1):4. PubMed ID: 21223554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
